Marc P. Bonaca, MD, a professor of medicine and Director of Vascular Research at the University of Colorado, talks with DocWire News about his work with the VOYAGER-PAD study. Dr. Bonaca also talks about rivaroxaban, the implications of the trial results, and the provides some take-home messages for practitioners.
The VOYAGER-PAD study was published in the New England Journal of Medicine and can be accessed here.
This is the first video in a two-part interview. The second part will talk about COVID-19 and its impact on the care of patients with atherosclerotic disease.